Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival
Journal article published in 2023 by
Omer Karrar 
,
Maymona Abdelmagid,
Masooma Rana ,
Moazah Iftikhar,
Kristen McCullough ,
Aref Al‐Kali ,
Hassan B. Alkhateeb,
Kebede H. Begna ,
Michelle A. Elliott ,
Abhishek Mangaonkar ,
Antoine Saliba ,
Mehrdad Hefazi Torghabeh ,
Mark R. Litzow ,
William Hogan,
Mithun Shah
and other authors.
,
Maymona Abdelmagid,
Masooma Rana ,
Moazah Iftikhar,
Kristen McCullough ,
Aref Al‐Kali ,
Hassan B. Alkhateeb,
Kebede H. Begna ,
Michelle A. Elliott ,
Abhishek Mangaonkar ,
Antoine Saliba ,
Mehrdad Hefazi Torghabeh ,
Mark R. Litzow ,
William Hogan,
Mithun Shah
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 